Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Changes in central arterial pressure waveforms during the normal menstrual cycle.

Nadia Ounis-Skali1, Gary F Mitchell, Caren G Solomon

  • 1Endocrinology, Diabetes and Hypertension Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|December 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Research opportunities to advance cardiovascular health through a planetary health lens.

American journal of preventive cardiology·2026
Same author

Interrelations of aortic spring function, cardiovascular disease risk factors, and left ventricular diastolic function: The Framingham Heart Study.

Physiological reports·2026
Same author

Continuing Glucagon-Like Peptide-1 Receptor Agonists Into the First Trimester of Pregnancy and Pregnancy Outcomes : A Target Trial Emulation Study Using Claims Information.

Annals of internal medicine·2026
Same author

Association of cardiometabolic disease with subclinical cardiac remodeling in men vs women in the Framingham Heart Study.

European journal of preventive cardiology·2026
Same author

Modifiable Correlates With Systemic Thromboxane Generation and Association With Cardiovascular Outcomes: Results From the Framingham Heart Study.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Associations of noninvasive measures of adiposity with aortic stiffness and microvascular function: The Jackson Heart Study.

American journal of preventive cardiology·2026

Arterial stiffness in women remains stable throughout the menstrual cycle, despite hormonal shifts. However, ventricular function indicators shorten during the luteal phase due to reproductive hormone and RAAS activity.

Area of Science:

  • Cardiovascular Physiology
  • Reproductive Endocrinology
  • Hormonal Regulation

Background:

  • Hormonal fluctuations, specifically estradiol and progesterone, during the menstrual cycle can influence cardiovascular and vascular function.
  • Elevated renin-angiotensin-aldosterone system (RAAS) hormones in the luteal phase may counteract estradiol's vascular effects.
  • Investigating these interactions is crucial for understanding reproductive health and cardiovascular dynamics.

Purpose of the Study:

  • To examine central arterial changes in response to menstrual cycle hormonal variations.
  • To assess cardiac function alterations across different menstrual cycle phases.
  • To evaluate the activity of the RAAS in relation to gonadal steroid fluctuations.

Main Methods:

  • 15 women were studied during the follicular and midluteal phases.

Related Experiment Videos

  • Estradiol, progesterone, RAAS hormones, and urine sodium/creatinine were measured.
  • Central hemodynamics, arterial stiffness, systolic ejection period (SEP), and systolic pressure time integral (SPTI) were assessed via carotid tonometry and Doppler flow.

    • Main Results:

    • Estradiol, progesterone, and RAAS hormone levels were significantly higher in the luteal phase.
    • SEP and SPTI were reduced during the luteal phase.
    • Arterial stiffness, blood pressure, and urine sodium-to-creatinine ratio remained consistent between phases.

    Conclusions:

    • Central arterial stiffness is unchanged between the follicular and midluteal phases in healthy women.
    • Systolic function indicators (SEP, SPTI) were shortened in the luteal phase, potentially due to direct hormonal or RAAS effects.
    • RAAS activation in the luteal phase may prevent estradiol-induced reductions in arterial stiffness.